Follow Flash Finance FollowTelegram
22tech score
/ 100

Sai Parenterals Limited (SAIPARENT) — Technical Setup

₹480.70 -7.90%   Weak Downtrend Volatility Expansion Strong bearish

As of 2026-11-02 close Sector: Pharma Drug Manufacturers - General All technical setups →

Summary

Sai Parenterals Limited is in a weak downtrend on the daily chart. RSI(14) is 45.9, MACD is above its signal line, ADX reads 21. Volume in the latest session was 3.0× its 20-day average. Over three months it has underperformed the Nifty 50 by 8.3 percentage points. Nearest support is ₹471.25 and resistance ₹491.68. Its technical score is 22/100 (strong bearish).

Trend (daily)
Bearish
Trend (weekly)
Bearish
Trend (monthly)
—
RSI (14)
45.92
MACD
Bullish
ADX (14)
21.35
Volume vs 20d avg
3.00×
Support
₹471.25 (−2.0%)
Resistance
₹491.68 (+2.3%)
RS vs Nifty (3M)
-8.33%
RS rating
50.00

🧮 How the 22/100 is built

Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.

Trend3/20
  • Close above 20-day EMA (-2.09)0/3
  • 20-day EMA above 50-day EMA0/3
  • 50-day EMA above 200-day EMA0/3
  • Close above 200-day SMA0/3
  • SuperTrend (10,3) pointing up3/3
  • ADX ≥ 20 with +DI above −DI (trend has strength) (21.35)0/3
  • Weekly trend up (above a rising 30-week average)0/2
Momentum8/20
  • RSI(14) in the bullish zone (55-70 best) (45.92)2/6
  • MACD line above its signal line4/4
  • MACD line above zero (-6.17)0/3
  • 12-day rate of change positive (-3.00)0/3
  • Stochastic %K above %D2/2
  • Outperforming the Nifty 50 over 3 months (-8.33)0/2
Volume0/20
  • On-balance volume rising over 20 sessions0/5
  • Chaikin Money Flow (20) positive (-0.16)0/5
  • More volume on up days than down days (20 sessions) (0.83)0/5
  • Close above 20-day VWAP (-2.15)0/5
Volatility5/20
  • Daily range (ATR%) contained — ≤2.5% scores full (5.19)2/6
  • Price in the upper half of its Bollinger Bands (0.39)2/5
  • Shallow drawdown from the 52-week high (-31.91)1/5
  • Volatility contracting (20-day volatility below its 6-month median) (100.00)0/4
Support / Resistance6/20
  • Room to the next resistance (≥8% scores full) (2.28)1/5
  • Support close below (a tight, definable stop) (1.97)5/5
  • Broke above a 20-day high in the last 5 sessions0/5
  • Within 5% of the 52-week high (-31.91)0/5

🧭 Regime: Weak Downtrend

Volatility Expansion — Bollinger width is in the 73th percentile of the last six months.

Suits: Defensive. Price is below its averages. Oversold bounces happen, but the path of least resistance is lower — wait for a base.

Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.

Opens the AI Backtester with the SuperTrend (10,3) rules for SAIPARENT — supertrend (10,3) flips to an uptrend.

🕰️ Multi-timeframe

TimeframeTrendRSI (14)MACD hist.
Monthly———
Weekly▼ Bearish49.68-9.69
Daily▼ Bearish45.923.38

Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: Bearish, weekly ADX 44.73.

📶 Volume & VWAP

Relative volume
3.00×
5d / 20d volume
1.52×
Volume ROC (10d)
+59.17%
Up/down volume
0.83×
OBV (20d)
Falling / flat
Chaikin MF (20)
-0.16
VWAP 20d
₹491.27 (-2.15%)
VWAP 50d
₹507.45 (-5.27%)
Anchored VWAP · 52W low
₹527.33 (-8.84%)
Anchored VWAP · 52W high
₹558.70 (-13.96%)
Anchored VWAP · YTD
₹527.33 (-8.84%)
Avg turnover (20d)
₹7.46 Cr

VWAPs are computed from daily bars (typical price × volume), not intraday ticks.

💪 Relative strength

vs Nifty 1M
-12.81%
vs Nifty 3M
-8.33%
vs Nifty 6M
+1.22%
vs Nifty 1Y
—
RS rating
50.00
Mansfield RS
—
vs Pharma index 3M
-14.35%
vs sector peers 3M
-11.83%

SAIPARENT ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.

🧱 Support & resistance

Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.

LevelPriceDistanceTouches
Resistance₹594.00+23.6%1
Resistance₹576.70+20.0%2
Resistance₹526.30+9.5%5
Resistance₹491.68+2.3%2
Close₹480.70—
Support₹471.25−2.0%3
Support₹441.35−8.2%1

52-week range: ₹400.00 – ₹706.00 (-31.91% from the high).

🌀 Fibonacci

Measuring the down-swing from ₹706.00 (2026-07-02) to ₹441.35 (2026-10-23). Price has retraced 14.9% of it.

RatioPriceDistance
23.6% retracement₹503.81+4.8% nearest
38.2% retracement₹542.45+12.8%
50.0% retracement₹573.67+19.3%S/R confluence
61.8% retracement₹604.90+25.8%
78.6% retracement₹649.36+35.1%
127.2% extension₹369.37-23.2%
161.8% extension₹277.80-42.2%
200.0% extension₹176.70-63.2%

Next Fibonacci time zone: 89 sessions from the swing start ≈ 2026-11-09 (approximate — exchange holidays are not modelled).

🕯️ Candlesticks (last 5 sessions)

Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.

↗️ Divergences

No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.

🏭 Pharma peers by technical score
Stock Close Chg Score Trend regimeRS rating (1-99)
DIVISLABDivi's Laboratories Limited ₹9,945.50 +1.69% 94 Uptrend 92.00
ACUTAASAcutaas Chemicals Limited ₹3,892.60 -2.77% 87 Uptrend 96.00
SMSPHARMASMS Pharmaceuticals Limited ₹504.15 -1.41% 87 Strong Uptrend 92.00
CORONACORONA Remedies Limited ₹2,171.10 +1.00% 86 Uptrend 84.00
ZYDUSLIFEZydus Lifesciences Limited ₹1,240.50 -0.40% 85 Uptrend 85.00
PPLPHARMAPiramal Pharma Limited ₹239.92 +0.42% 83 Strong Uptrend 90.00
DRREDDYDr. Reddy's Laboratories Limited ₹1,342.00 -0.74% 82 Strong Uptrend 76.00
AARTIDRUGSAarti Drugs Limited ₹453.80 +4.27% 81 Strong Uptrend 77.00
ALIVUSAlivus Life Sciences Limited ₹1,447.60 +2.28% 81 Strong Uptrend 92.00
GLANDGland Pharma Limited ₹3,066.60 -0.95% 80 Uptrend 94.00
🔗 More on SAIPARENT

⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI